Trademark: 97923157
Word
IMMUNOTREX
Status Date
Tuesday, May 7, 2024
Filing Date
Friday, May 5, 2023
Published for Opposition
Tuesday, March 12, 2024
42 Pharmaceutical research services; Consulting services in the field of pharmaceutical research; Development of pharmaceutical preparations and medicines; Laboratory research services relating to pharmaceuticals; Testing of pharmaceuticals; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy
The mark consists of the letters "IMMUNOTRE" in a blue sans serif font, with a line running through those letters, a blue letter "X" stylized as a chromosome pair and a circle representing the centromere of the chromosome, any white within and outside the blue letters and chromosome is background only and not claimed as a feature of the mark.
The color(s) blue is/are claimed as a feature of the mark.
May 9, 2023
New Application Entered
May 25, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
May 25, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
May 25, 2023
Teas Change Of Correspondence Received
Jun 5, 2023
New Application Office Supplied Data Entered
Jun 6, 2023
Notice Of Design Search Code E-Mailed
Jan 31, 2024
Assigned To Examiner
Jan 31, 2024
Examiners Amendment -Written
Jan 31, 2024
Examiners Amendment E-Mailed
Jan 31, 2024
Notification Of Examiners Amendment E-Mailed
Jan 31, 2024
Examiner's Amendment Entered
Jan 31, 2024
Approved For Pub - Principal Register
Feb 21, 2024
Official Gazette Publication Confirmation E-Mailed
Feb 21, 2024
Notification Of Notice Of Publication E-Mailed
Mar 12, 2024
Published For Opposition
Mar 12, 2024
Official Gazette Publication Confirmation E-Mailed
May 7, 2024
Noa E-Mailed - Sou Required From Applicant
Trademark Alertz updated from USPTO on 2030-01-24
